跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ISOCAINE (MEPIVACAINE HCL) INJECTION 3% - HSA Drug Approval Details
Approvals
/
HSA
/
ISOCAINE (MEPIVACAINE HCL) INJECTION 3%
Approved
THERAPEUTIC
ISOCAINE (MEPIVACAINE HCL) INJECTION 3%
NOVOCOL PHARMACEUTICAL OF CANADA, INC. (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Oct 24, 2014
Approval ID
836ecdf26b1d0880
Company
NOVOCOL PHARMACEUTICAL OF CANADA, INC. (CANADA)
Type
Therapeutic
Approval Details
Approval Id
836ecdf26b1d0880
Drug Name
ISOCAINE (MEPIVACAINE HCL) INJECTION 3%
Product Name
ISOCAINE (MEPIVACAINE HCL) INJECTION 3%
Approval Number
SIN14649P
Approval Date
2014-10-24
Registrant
N.K. LUCK (S) PTE LTD
Licence Holder
N.K. LUCK (S) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION
Route Of Administration
SUBCUTANEOUS
Atc Code
N01BB03
Atc Item Name
mepivacaine
Pharma Manufacturer Name
n.k. luck (s) pte ltd
Active Ingredients
Mepivacaine HCl
30 mg/mL
MEPIVACAINE HCL
30 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 24, 2014
Approval ID
836ecdf26b1d0880
Type
Therapeutic
Back to HSA Approvals